1. 1ODouble PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer. (13th May 2019) Authors: Vasan, N; Razavi, P; Johnson, J L; Shao, H; Reznik, E; Smith, M L; Sebra, R; Cantley, L C; Scaltriti, M; Baselga, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗